S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NASDAQ:ALXNAlexion Pharmaceuticals News Headlines

$103.28
-0.62 (-0.60 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$102.31
Now: $103.28
$104.16
50-Day Range
$101.49
MA: $109.43
$119.35
52-Week Range
$72.67
Now: $103.28
$125.52
Volume1.85 million shs
Average Volume2.28 million shs
Market Capitalization$22.64 billion
P/E Ratio27.62
Dividend YieldN/A
Beta1.39

Headlines

Alexion Pharmaceuticals (NASDAQ ALXN) News Headlines

Source:
DateHeadline
Alexion Pharmaceuticals (NASDAQ: ALXN) Bounces Into Earnings (ALXN)Alexion Pharmaceuticals (NASDAQ: ALXN) Bounces Into Earnings (ALXN)
marketbeat.com - August 3 at 2:09 PM
Alexion Pharmaceuticals (NASDAQ:ALXN) Lowered to "C" at TheStreetAlexion Pharmaceuticals (NASDAQ:ALXN) Lowered to "C" at TheStreet
marketbeat.com - August 1 at 7:08 AM
Alexion Announces Appointment of First Chief Diversity OfficerAlexion Announces Appointment of First Chief Diversity Officer
finance.yahoo.com - August 6 at 12:43 PM
J.P. Morgan: These 2 Healthcare Stocks Are Must-Watch NamesJ.P. Morgan: These 2 Healthcare Stocks Are Must-Watch Names
finance.yahoo.com - August 5 at 11:10 AM
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Short Interest UpdateAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Short Interest Update
americanbankingnews.com - August 4 at 4:15 AM
Alexion Pharmaceuticals (NASDAQ:ALXN) Releases  Earnings Results, Beats Estimates By $0.81 EPSAlexion Pharmaceuticals (NASDAQ:ALXN) Releases Earnings Results, Beats Estimates By $0.81 EPS
www.americanbankingnews.com - July 31 at 7:44 PM
Alexion Pharmaceuticals (NASDAQ:ALXN) PT Raised to $163.00Alexion Pharmaceuticals (NASDAQ:ALXN) PT Raised to $163.00
www.americanbankingnews.com - July 31 at 1:40 PM
Alexion Pharmaceuticals (NASDAQ:ALXN) PT Lowered to $151.00 at Raymond JamesAlexion Pharmaceuticals (NASDAQ:ALXN) PT Lowered to $151.00 at Raymond James
www.americanbankingnews.com - July 31 at 12:24 PM
Alexion Pharmaceuticals (ALXN) Q2 2020 Earnings Call TranscriptAlexion Pharmaceuticals (ALXN) Q2 2020 Earnings Call Transcript
finance.yahoo.com - July 31 at 11:42 AM
Alexion Pharmaceuticals (NASDAQ:ALXN) Price Target Raised to $155.00 at SunTrust BanksAlexion Pharmaceuticals (NASDAQ:ALXN) Price Target Raised to $155.00 at SunTrust Banks
www.americanbankingnews.com - July 31 at 9:58 AM
William Blair Lowers Alexion Pharmaceuticals (NASDAQ:ALXN) to HoldWilliam Blair Lowers Alexion Pharmaceuticals (NASDAQ:ALXN) to Hold
www.americanbankingnews.com - July 31 at 8:19 AM
Got $200? Here Are 3 Smart Stocks to Invest in NowGot $200? Here Are 3 Smart Stocks to Invest in Now
finance.yahoo.com - July 31 at 6:41 AM
Why Alexion Could Have the Most Upside of All Established Pharma & Biotech StocksWhy Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks
247wallst.com - July 30 at 11:02 PM
Alexion Pharmaceuticals (ALXN) "Hold" Rating Reiterated at OppenheimerAlexion Pharmaceuticals' (ALXN) "Hold" Rating Reiterated at Oppenheimer
www.americanbankingnews.com - July 30 at 5:08 PM
Alexion beats Q2 consensus; revenue guidance raise tops estimatesAlexion beats Q2 consensus; revenue guidance raise tops estimates
seekingalpha.com - July 30 at 1:01 PM
Alexion (ALXN) Beats on Q2 Earnings & Sales, Ups 20 GuidanceAlexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 Guidance
finance.yahoo.com - July 30 at 1:01 PM
Whats Behind Alexion Pharmaceuticals Strong Q2 ResultsWhat's Behind Alexion Pharmaceuticals' Strong Q2 Results
www.fool.com - July 30 at 1:01 PM
Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue EstimatesAlexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue Estimates
finance.yahoo.com - July 30 at 1:01 PM
Alexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 GuidanceAlexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 Guidance
finance.yahoo.com - July 30 at 1:01 PM
What's Behind Alexion Pharmaceuticals' Strong Q2 ResultsWhat's Behind Alexion Pharmaceuticals' Strong Q2 Results
finance.yahoo.com - July 30 at 1:01 PM
Alexion Reports Second Quarter 2020 ResultsAlexion Reports Second Quarter 2020 Results
www.marketwatch.com - July 30 at 8:00 AM
Alexion Pharmaceuticals EPS beats by $0.53, beats on revenueAlexion Pharmaceuticals EPS beats by $0.53, beats on revenue
seekingalpha.com - July 30 at 8:00 AM
Alexion Raises 2020 Total Revenues, Non-GAAP EPS Guidance - Quick FactsAlexion Raises 2020 Total Revenues, Non-GAAP EPS Guidance - Quick Facts
www.nasdaq.com - July 30 at 8:00 AM
Recap: Alexion Pharmaceuticals Q2 EarningsRecap: Alexion Pharmaceuticals Q2 Earnings
www.benzinga.com - July 30 at 8:00 AM
Alexion Pharmaceuticals Q2 2020 Earnings PreviewAlexion Pharmaceuticals Q2 2020 Earnings Preview
seekingalpha.com - July 29 at 4:59 PM
Can Alexion Pharmaceuticals Inc withstand the coronavirus chaos?Can Alexion Pharmaceuticals Inc withstand the coronavirus chaos?
uk.finance.yahoo.com - July 28 at 12:26 AM
Alexion Pharmaceuticals (NASDAQ:ALXN) Shares Up 5.3%Alexion Pharmaceuticals (NASDAQ:ALXN) Shares Up 5.3%
www.americanbankingnews.com - July 27 at 8:07 PM
Q2 2020 EPS Estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Raised by SVB LeerinkQ2 2020 EPS Estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Raised by SVB Leerink
www.americanbankingnews.com - July 27 at 1:14 AM
Contrasting Insmed (NASDAQ:INSM) & Alexion Pharmaceuticals (NASDAQ:ALXN)Contrasting Insmed (NASDAQ:INSM) & Alexion Pharmaceuticals (NASDAQ:ALXN)
www.americanbankingnews.com - July 26 at 12:42 PM
Earnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to DeclineEarnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to Decline
finance.yahoo.com - July 23 at 6:00 PM
Q2 2021 Earnings Estimate for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Issued By Piper SandlerQ2 2021 Earnings Estimate for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Issued By Piper Sandler
www.americanbankingnews.com - July 23 at 9:10 AM
Alexion Pharmaceuticals (ALXN) Scheduled to Post Earnings on ThursdayAlexion Pharmaceuticals (ALXN) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 23 at 3:08 AM
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Receives Average Rating of "Buy" from BrokeragesAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 23 at 1:26 AM
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Expected to Post Quarterly Sales of $1.26 BillionAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Expected to Post Quarterly Sales of $1.26 Billion
www.americanbankingnews.com - July 20 at 4:12 AM
$2.53 EPS Expected for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) This Quarter$2.53 EPS Expected for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) This Quarter
www.americanbankingnews.com - July 18 at 8:38 AM
Inozyme buys ENPP1 deficiency program assets from AlexionInozyme buys ENPP1 deficiency program assets from Alexion
seekingalpha.com - July 17 at 11:14 PM
Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion PharmaceuticalsInozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals
feeds.benzinga.com - July 17 at 7:13 PM
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
finance.yahoo.com - July 16 at 9:22 AM
Wedbush Comments on Alexion Pharmaceuticals, Inc.s Q2 2020 Earnings (NASDAQ:ALXN)Wedbush Comments on Alexion Pharmaceuticals, Inc.'s Q2 2020 Earnings (NASDAQ:ALXN)
www.americanbankingnews.com - July 16 at 7:32 AM
Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - July 15 at 6:07 PM
Drugmaker Alexion Needs to Ditch Its Acquisitions Strategy, Analyst WritesDrugmaker Alexion Needs to Ditch Its Acquisitions Strategy, Analyst Writes
finance.yahoo.com - July 14 at 9:35 AM
Alexion Pharmaceuticals, Inc.'s (NASDAQ:ALXN) Stock Been Rising: Are Strong Financials Guiding The Market?Alexion Pharmaceuticals, Inc.'s (NASDAQ:ALXN) Stock Been Rising: Are Strong Financials Guiding The Market?
finance.yahoo.com - July 13 at 1:32 PM
FY2020 EPS Estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Raised by AnalystFY2020 EPS Estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Raised by Analyst
www.americanbankingnews.com - July 13 at 2:32 AM
Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)
seekingalpha.com - July 11 at 7:17 AM
Nasdaq 100 Movers: ALXN, BIIBNasdaq 100 Movers: ALXN, BIIB
www.marketwatch.com - July 8 at 3:18 PM
Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?
finance.yahoo.com - July 8 at 3:18 PM
Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery CaseAlexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case
finance.yahoo.com - July 6 at 9:30 AM
Alexion Pharma Agrees To Settle Charges Of FCPA ViolationsAlexion Pharma Agrees To Settle Charges Of FCPA Violations
www.nasdaq.com - July 3 at 8:30 AM
Alexion pays $21 million resolving charges of breaking U.S. foreign corruption law: SECAlexion pays $21 million resolving charges of breaking U.S. foreign corruption law: SEC
www.reuters.com - July 2 at 2:20 PM
Why the Earnings Surprise Streak Could Continue for Alexion (ALXN)Why the Earnings Surprise Streak Could Continue for Alexion (ALXN)
finance.yahoo.com - July 2 at 2:20 PM
Alexion Completes Acquisition of PortolaAlexion Completes Acquisition of Portola
finance.yahoo.com - July 2 at 9:20 AM
Alexion pays $21 mln resolving charges of breaking U.S. foreign corruption law -SECAlexion pays $21 mln resolving charges of breaking U.S. foreign corruption law -SEC
finance.yahoo.com - July 2 at 9:20 AM
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.